Recent whole-exome sequencing and confirmatory IHC studies show high HER2/neu expression in ∼35% of patients with uterine serous carcinoma (USC) (Zhao et al., 2013; Rottmann et al., 2020). The gene discussed is ERBB2; the disease is endometrial serous adenocarcinoma.